Breast cancer screening in sub-Saharan Africa: a systematic review and ethical appraisal

Abstract

Background The aim of this systematic review was to evaluate the evidence and clinical outcomes of screening interventions and implementation trials in sub-Saharan Africa (SSA) and also appraise some ethical issues related to screening in the region through quantitative and qualitative narrative synthesis of the literature. Methods We searched Pubmed, OvidMEDLINE, Embase, and Web of Science to identify studies published on breast cancer screening interventions and outcomes in SSA. Descriptive statistics were used to summarize the frequency and proportions of extracted variables, and narrative syntheses was used to evaluate the clinical outcomes of the different screening modalities. The mixed methods appraisal tool was used to assess the quality of studies included in the review. Results Fifteen studies were included, which consisted of 72,572 women in ten countries in SSA. 63% (8/15) of the included publications evaluated Clinical Breast Examination (CBE), 47% (7/15) evaluated mammography and 7% (1/15) evaluated ultrasound screening. The cancer detection rate was < 1/1000 to 3.3/1000 and 3.3/100 to 56/1000 for CBE and mammography screening respectively. There was a lot of heterogeneity in CBE methods, target age for screening and no clear documentation of screening interval. Cost-effective analyses showed that CBE screening linked to comprehensive cancer care is most cost effective. There was limited discussion of the ethics of screening, including the possible harms of screening in the absence of linkage to care. The gap between conducting good screening program and the appropriate follow-up with diagnosis and treatment remains one of the major challenges of screening in SSA. Discussion There is insufficient real-world data to support the systematic implementation of national breast cancer screening in SSA. Further research is needed to answer important questions about screening, and national and international partnerships are needed to ensure that appropriate diagnostic and treatment modalities are available to patients who screen positive.

Oncoplastic Breast-Conserving Surgery in African Women: A Systematic Review

“…Patients in those settings are more likely to be diagnosed early because of the presence of a wellstructured screening program, the availability of specialists, and the existence of effective health care systems. 45 Breast-conserving surgery can remove macroscopic disease in many women with early-stage breast cancer; however, microscopic tumor foci may remain in the conserved breast and, if left untreated, may result in locoregional recurrence or life-threatening distant metastases, or even both. 46 Radiotherapy after breast-conserving surgery not only significantly reduces the risk of breast cancer recurrence, but also moderately reduces the risk of breast cancer mortality.…”

Breast cancer epidemiology and sociodemographic differences in BRICS-plus countries from 1990 to 2019: An age period cohort analysis

“…In the past, BC incidence was high in most developed countries. With the period effect and the continuous improvement of medical level, early diagnosis enabled BC patients to receive more timely and effective treatment, which reduced the mortality of BC in these regions, and continued to increase the survival rate ( Martei et al, 2022 ). As we summarized earlier, SDI is negatively correlated with the adverse prognosis and positively correlated with incidence of BC.…”

Factors associated with the uptake of clinical breast examination among women of reproductive age in Lesotho: analysis of a national survey

“…Approximately 80% of women who are diagnosed at the late stages appear in health facilities with locally advanced and metastatic disease in SSA [ 7 ]. Substantial efforts have been made to reduce the burden of breast cancer in SSA focusing on improving early detection combined with effective treatment in the early stages in order to improve the survival rate [ 8 ]. Despite the efforts made, the participation of women in breast cancer screening remains low [ 9 – 11 ].…”